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Abstract 
Acetazolamide (AZ), a molecule frequently used to treat different neurological syndromes, 
is an inhibitor of the carbonic anhydrase (CA), an enzyme that regulates pH inside and 
outside cells. We combined fluorescent FM styryl dyes and electrophysiological 
techniques at ex vivo levator auris longus neuromuscular junctions (NMJs) from mice to 
investigate the modulation of synaptic transmission and vesicle recycling by AZ. 
Transmitter release was minimally affected by AZ, as evidenced by evoked and 
spontaneous end-plate potential measurements. However, optical evaluation of vesicle 
exocytosis elicited by 50 Hz stimuli showed a strong reduction in fluorescence loss in AZ 
treated NMJ, an effect that was abolished by bathing the NMJ in Hepes.  The remaining 
dye was quenched by bromophenol, a small molecule capable of diffusing inside vesicles. 
Furthermore, in transgenic mice expressing Synaptophysin-pHluorin (SypHy), the 
fluorescence responses of motor nerve terminals to a 50 Hz train of stimuli was decrease 
to a 50% of controls in the presence of AZ. Immunohistochemistry experiments to 
evaluate the state of the Myosin light chain kinase (MLCK), an enzyme involved in vesicle 
recycling, demonstrated that MLCK phosphorylation was much stronger in the presence 
than AZ than in its absence in 50 Hz stimulated NMJs. We postulate that AZ, via cytosol 
acidification and activation of MLCK, shifts synaptic vesicle recycling to a fast (kiss-and-
run) mode, which changes synaptic performance. These changes may contribute to the 
therapeutic action reported in many neurological syndromes like ataxia, epilepsy, and 
migraine. 
  
Introduction 
The adult vertebrate neuromuscular junction (NMJ) is an extremely dependable synapse. 
In order to ensure effective excitation of the postsynaptic muscle fiber, the presynaptic 
terminal must exocytose a large number of vesicles with each stimulus and must be able 
to resupply a comparable number of vesicles by subsequent endocytosis or by recruitment 
from the reserve pool. Thus, the regeneration of synaptic vesicles after exocytosis at nerve 
terminals is critical for the maintenance of neurotransmission across a wide range of 
stimulation frequencies. 
In the 1970´s, Heuser and Reese described that vesicle fusion is followed by full collapse of 
the vesicle membrane into the plasma membrane and the recovery of the synaptic vesicle 
occurs at a slow speed (Heuser and Reese, 1979; Heuser, 1989b). At the same time, 
Ceccarelli et al. (1972, 1973) proposed that vesicle fusion involves the opening of a small 
pore, termed the ‘fusion pore’ (Breckenridge et al., 1987; Zimmerberg et al., 1987), 
followed by its rapid closure without full dilation and collapse. This model, referred to as 
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‘kiss-and-run’ (Fesce et al., 1994; He and Wu, 2007) was based mainly on the electron 
microscopic observations of motor nerve terminals but further support was obtained with 
electrophysiological and fluorescent methods in other preparations (Harata et al., 2006; 
Zhang et al.,2009; Alés et al., 1999; Alvarez de Toledo et al., 1993). 
At the NMJ, frequency-dependent changes in the spatial location of endocytosis were 
demonstrated by Gaffield et al. (2009) based on the observation that exocytosis and 
endocytosis sites colocalize during high (100 Hz) but not lower (40 Hz) frequency of 
stimulation. The regulation of endocytosis at different stimulation frequencies is not well 
known yet but in a series of papers by Polo Parada et al. (2001, 2004, 2005) an 
intracellular signaling pathway involving myosin light chain kinase (MLCK) and myosin II 
was shown to be required for effective transmission at adult mouse NMJs at high (100 Hz 
and above) but not at low (10 Hz) stimulus frequencies (Maeno-Hikichi et al., 2011).  
High frequency stimulation (HFS) results in changes in internal nerve terminal pH 
according to studies performed at NMJ constitutively expressing pH-sensitive Yellow 
Fluorescent Protein (Zhang et al., 2010). Interestingly, Ca
2+
 influx elicited by action 
potential trains (12.5-100 Hz) evokes a biphasic response consisting in a brief acidification 
followed by a prolonged alkalinization that outlasts the stimulation train Key components 
of vesicular neurotransmitter release can be affected by cytosolic pH. For example, 
acidification inhibits endocytosis (Dejonghe et al., 2016; Heuser, 1989a; Lindgren et al., 
1997; Sandvig 1987) and alkalinization seems to facilitate endocytosis (Zhang et al., 2010). 
Physiologically, one of the main regulators of the cellular pH is the enzyme CA, which 
catalyzes the rapid and reversible conversion of CO2 and water to HCO3
-
 and H
+
 (Maren, 
1967). In fact, the initial acidification reported by Zhang et al (2010) is greatly enhanced by 
Acetazolamide (AZ), an inhibitor of the CA enzyme  
To get more insight into the regulation of vesicle recycling we studied the effect of AZ on 
synaptic transmission with electrophysiology, FM styryl dye (Betz and Bewick, 1992; 
Hoopmann et al., 2012), pHlourin (Tabares et al., 2007), and immunohistochemical 
measurements. Our results indicate that pH changes at nerve terminals during sustained 
electrical stimulation regulates neurotransmission and suggest that acidification, via 
activation of the MLKC pathway, switches the mode of exo/endocytosis to a fast vesicle 
recycling mode. 
Materials and Methods 
  
Animal protocols 
Experiments were carried out on the left LAL muscle of male C57BL/6J mice 
(https://www.jax.org/strain/000664). Animals were supplied by the animal house of the 
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school of Exacts and Natural Sciences of the University of Buenos Aires. Animals were 
cared for in accordance with national guidelines for the human treatment of laboratory 
animals, similar to those of the US National Institutes of Health. Animals were 
anesthetized with an overdose of 2% tribromoethanol (0.15 mL ⁄ 10 g body weight) 
injected into the peritoneal cavity and exsanguinated immediately. The muscle with its 
nerve supply was excised and dissected on a Sylgard-coated Petri dish containing 
physiological saline solution of the following composition (in mm): 137 NaCl, 5 KCl, 2 
CaCl2, 1 MgSO4, 12 NaHCO3, 1 Na2HPO4 and 11 glucose; continuously bubbled with 95% 
O2 ⁄ 5% CO2; pH 7.4. The preparation was then transferred to a 1,5 ml recording chamber. 
Experiments were performed at room temperature (20–23 ºC). 
  
Electrophysiological recordings 
Evoked (EPP) and spontaneous (MEPPs) endplate potentials were recorded with 
conventional intracellular microelectrodes filled with 3M KCl (20–40 MΩ). 
Electrophysiological experiments were performed in bicarbonate buffer. The nerve was 
stimulated via two platinum electrodes isolated with grease coupled to a pulse generator 
(Grass S88, Grass Inst., USA).To avoid muscle contraction, µ-conotoxin GIIIB (1µM) was 
used. Intracellular recordings were obtained using an Axoclamp 2A amplifier in 
combination with a Digidata 1440A interface and commanded with pClamp 8.2 software 
(Axon Instruments, Molecular Devices, CA). 
In each muscle fiber where quantal output was estimated, MEPPs were recorded during 
100 s followed by a low frequency (0.33 Hz) stimulation during 36 s. AZ treated muscles 
were incubated in a 100 µM AZ solution for 30 min to 1 h before studied. Quantal content 
(QC) was determined by a direct method and corrected for non-lineal summation 
(McLachlan and Martin, 1981), using the formula below and MEPPs mean value from the 
last 20 s of 100 s recording.  
QC= E/(m*(1-0.8E/Vm)) 
where E is the amplitude of an individual EPP, m is the mean amplitude of MEPPs, and Vm 
is the membrane potential. Amplitudes for both EPP and MEPPs were normalized to Vm = 
-70 mV, assuming 0 mV as the reversal potential for acetylcholine (ACh) nicotinic 
receptors. 
 
High frequency and bursts stimulation protocol: High frequency (50 Hz) nerve stimulation 
was applied up to a total of 7300 pulses. Normalized EPP amplitudes and EPPs summed 
amplitudes were plotted for control and AZ treated muscles. 
During the ¨bursts¨ protocol, the nerve was stimulated with trains at high frequency (50 
Hz) for 1 s followed by 1 s of rest. This sequence was repeated for a period of 1 min for 
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control and AZ treated muscles. Normalized amplitude of the first and last EPP was 
analyzed for the 1
st
, 5
th
, 10
th
, 15
th
, 20
th
 and 30
th
 train. 
Absolut depression was quantified as the difference in amplitude between the first EPP of 
the first train and the last EPP of each short tetanic train. Relative depression was 
quantified as the difference in amplitude between the first and the last EPP inside each 
short tetanic train (1
st
, 5
th,
 10
th
, 15
th
, 20
th
 and 30
th
 short tetanic trains were analyzed). For 
statistical calculations, student’s t-test for differences analysis, and f-test for variance, in 
SigmaPlot 10.0 and Origin Pro 8 software were used. 
  
FM 2-10 Imaging 
FM 2-10 imaging experiments were performed in bicarbonate buffer and Hepes buffer (10 
mM). To avoid muscle contraction, α-bungarotoxin (5 µM) was applied to the bath. All 
images were acquired with a high performance camera (Quantix camera, Photometrics, 
Tucson, AZ, USA) and an optical filter changer Lambda 10-2 (Sutter Instrument, Novato, 
CA). Long loading protocol was used to fully load vesicle recycling pool (Perissinotti and 
Uchitel, 2010). Nerve terminals were incubated for 5 min with FM2-10 prior to the loading 
by 20 Hz nerve stimulation during 10 min. After 20 min washing, images were acquired to 
quantify the maximal loading. During a resting period of 30 min to 1 h, the muscles were 
treated or not with AZ (100 µM) and thereafter, the vesicle unloading protocol was 
performed at the selected stimulation frequency. Fluorescence images were acquired 
every 3 s during unloading. 
Bromophenol Blue assay: After FM loading protocol and AZ treatment, bromophenol blue 
(2 mM) was incubated for 5 min and kept during the following unloading protocol as 
described before.   
Analysis of FM fluorescence signals 
Fluorescence was quantified as the percentage of the maximum signal after load. Absolute 
fluorescence was converted to percentage of fluorescence with the following equation: 
%F(t)= (F(t)-Fnv/(Fmax-Fnv)) x 100 
Where F(t) is the absolute fluorescence at time t, Fmax the absolute fluorescence after 
maximum loading and Fnv is the non-vesicular fluorescence background (fluorescence 
remaining after treatment with 90mM K+ for 5 min.) 
Images were analyzed with Image J 1.49 software. 
  
Live imaging acquisition and analysis 
Transgenic mice expressing SypHy as a fusion protein, under the neuron-specific promoter 
Thy 1.2 were used. This tool allowed us to study synaptic vesicle recycling in motor nerve 
terminals from the LAL muscle in real time by monitoring the fluorescence changes taking 
place during exocytosis and endocytosis. To monitor fluorescence changes, a Yokogawa 
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CSU-X1 spinning disk system (3i, Göttingen, Germany) mounted on an upright BX61WI 
microscope (Olympus,  Spain ) was used. For excitation, a 488 nm laser was used. Images 
were acquired by means of a back-thinned EM-CCD camera C9100-13 (Hamamatsu, Spain) 
with an effective number of pixels of 512(H) x 512(V), and a pixel size of 16 x 16 μm. 
Images were acquired at 1 frames/s with commercial software (SlideBookTM 5.0, 3i). 
Before analysis, images were aligned, and regions of interest (ROIs) selected. After 
background subtraction, fluorescence changes (ΔF) were normalized with respect to the 
basal level (F0). In all experiments, the nerve was stimulated twice at 50 Hz, during 75 s, 
first in the control solution, and after 30 min incubation in 100 μM AZ (final DMSO 
concentration: 0.1%). Recordings with only DMSO were not significantly different to 
controls. All experiments reported include the results of at least three animals per 
genotype. All experiments were performed according to the guidelines of the European 
Council Directive for the Care of Laboratory Animals. 
  
LAL phospho-myosin light chain 2 immunostaining 
LAL muscles were dissected, as previously described, and incubated in saline with or 
without AZ (100 μM) for 30 min. Nerve were stimulated at 50 Hz for 10 min, and 30 s 
before the end of stimulation muscles were fixed in 4% paraformaldehyde in PBS (pH 7.4) 
for 10 minutes at 4 °C, containing b-glycerophosphate (5 mM) and potassium fluoride  (5 
mM) to prevent dephosphorylation, and stored in 30 % sucrose-PBS for cryoprotection (24 
h at 4 °C). LAL were permeabilized and blocked with 10 % fetal calf serum (FCS), 2 % 
bovine serum albumin (BSA), 0.5 % Triton in PBS (blocking solution) for 1 h at room 
temperature. Muscles were incubated overnight at 4 ºC with an antibody against 
phospho-myosin light chain 2 (Ser19, anti-pMLC2 polyclonal, Cell Signaling Technology 
Inc., Danvers, MA, USA; 1:50 dilution in 1% NGS, 1% BSA, and 0.1% Triton X-100 in PBS). 
After washing with PBS, the primary antibody was visualized with a subsequent 2 h 
incubation using a secondary antibody (anti-mouse Alexa Fluor 647, Invitrogen, Carlsbad, 
CA; 1:1000 dilution in PBS) and postsynaptic nicotinic acetylcholine receptors with 
fluorochrome-conjugated α-bungarotoxin- FITC (Invitrogen Argentina S.A., Buenos Aires, 
Argentina; 1:500) at room temperature. 12-O-Tetradecanoylphorbol-13-acetate (TPA, 20 
μM, gently provided by Prof. Eduardo Cánepa) was added to the bath for 1 h, to significant 
increased the pMLC fluorescence intensity, as previously described (Maeno-Hikichi et al., 
2011). 
After immunostaining, images were acquired with an FV300 confocal fluorescence 
microscope (Olympus Optical, Tokyo, Japan) equipped with an image-acquisition system 
and Fluoview 3.3 software (Olympus Optical).  For each endplate, pMLC mean 
fluorescence intensity was obtained by densitometry analysis using stacks of 20–35 
images (60x magnification, 1-μm interval) with a confocal microscope, always maintaining 
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the same pinhole (airy 2) and the same confocal settings for comparison purpose between 
different samples. The resulting images were analyzed by using Image J software 1.42 
software (National Institutes of Health, Bethesda, MD, http://imagejdocu.tudor.lu). 
Background fluorescence intensity, adjacent to the endplate, was subtracted to correct 
the pMLC mean endplate fluorescence intensity. 
  
Statistics 
Results were expressed as means normalized fluorescence intensity± SEM; n refers to the 
number of endplates, obtained from 3 different experiments. For statistical calculations, 
we used SigmaStat 3.11 (Systat Software, Chicago, IL, USA). For multiple comparisons 
values were analyzed with the Kruskal-Wallis test, followed by the Tukey-Kramer post hoc 
test. Two groups of data were considered statistically different if p ≤ 0.05. 
  
Toxin and chemicals. 
Acetazolamide (SIGMA) was dissolved in dimethyl sulfoxide (DMSO) at 100 
mM.  Tribromoethanol, α-bungarotoxin and all salts of analytical grade were purchased 
from Sigma (St. Louis, MO), and µ-conotoxin GIIIB was purchased from Alomone Labs 
(Jerusalem, Israel). Sucrose was purchased from Merck (Darmstadt, Germany). 
  
RESULTS 
Spontaneous and evoked transmitter release in AZ treated NMJs 
To gain insight on the role of CA on transmitter release we studied the effect of its 
inhibition by AZ on spontaneous and evoked release of acetylcholine at the mouse NMJ. 
Muscle fiber intracellular recordings of synaptic activity revealed that AZ had no effect on 
MEPP amplitude (0,72±0,04 mV in AZ treated vs. 0,71±0,04 mV in control), but AZ treated 
muscles showed an increase in MEPPs frequency (3,5±0,3 MEPPs/s in AZ treated vs 
2,4±0,2 MEPPs/s in control) (n=69 fibers/8 AZ treated muscles and n=40 fibers /7 control 
muscles ) (**p=0.0006), (Fig. 1A, B). 
Evoked nerve endplate potentials (EPPs) were recorded every 2 s in 2 mM Ca
2+
/1mM 
Mg
2+
, in the presence of µ-conotoxin GIIIB (1 µM) to avoid muscle contraction. Quantal 
content was estimated using the amplitude of the MEPPs previously measured in the 
same muscle fiber (direct method, corrected for nonlinear summation, see Materials and 
methods). A small but significant decrease in quantal content was observed. Mean 
quantal content in AZ treated muscles was 24.4±1.3 (n = 59/7) and in control was 30.4±1.5 
(n = 34/6), (*p=0.007) (Fig. 1C). 
Page 8 of 27Synapse
This article is protected by copyright. All rights reserved.
 
8 
To further assess the effect of carbonic anhydrase on exocytosis and vesicle 
replenishment, transmitter release at HFS was studied in AZ treated NMJs. During 50 Hz 
stimulation trains EPP amplitudes underwent short-term depression (Fig. 1D & F). The 
time course and the final level of depression were not affected by AZ treatment. (y0 
control 0.25±0.02 mV and AZ 0.19±0.03 mV; tau control 31±5 s and 31±5 s tau AZ; n: 
control=19/5 and AZ=12/4). Furthermore, the summed normalized amplitudes during HFS 
trains showed no significant differences between control and AZ treated muscles (Fig. 1E; 
n = 19/5 in control and 12/4 in AZ)  
To further analyze the effect of AZ on vesicle replenishment, short bursts of HFS were 
applied repetitively during 60 s (50 Hz, 1 s, every 2 s). The relative depression after 30 
bursts was of 23±3% in control vs 21±3% in AZ treated muscle. Furthermore, the 
depression at the end of the 30
st
 burst was also similar (52±5% control vs 42±7% AZ 
treated). In summary, no differences were observed between control and AZ treated 
muscles (Fig 1G). 
These results suggested that CA inhibition has no effect on ACh release and ACh 
replenishment except for a small reduction of quantal content value in agreement with 
previously reported data by Kaja et al. (2008). 
  
Differential effect of AZ at different stimulation frequencies  
In order to have a different approach on the influence of carbonic anhydrase activity on 
the dynamics of exo- and endocytosis we examined the time course of FM 2-10  
destaining at motor nerve terminals in the presence or not of AZ (Fig 2A). Nerve terminals 
were maximally loaded with FM2-10 (10 min at 20 Hz, see Materials and methods, and 
Perissinotti et al., 2008), and then destained at different frequencies.  
Figure 2B shows the time course of nerve terminal destaining at 10, 50 and 100 Hz. In 
control experiments, at 10 and 50 Hz, fluorescence loss was rapid with approximately 50% 
of the dye being released by the 5000
th
 stimulus (Fig. 2B). However, with 100 Hz, only 30% 
of the fluorescence was lost by the same amount of stimulus. In the presence of AZ, no 
effect on the kinetics of FM fluorescence loss was seen at 10 Hz stimulation, but at 50 Hz 
only 20% of destaining by the 5000
th
 stimulus was observed. At 100 Hz stimulation, 
fluorescence loss was already slow in control and AZ-treated terminals (Fig. 2C).  We next 
compared vesicle exocytosis estimated by quantal content and by FM destaining (Fig 2E) 
at the same stimulation frequency and confirmed the discrepancy between these two 
measurements.  
To investigate if indeed the slowing effect of AZ on FM fluorescence loss upon stimulation 
was due to pH changes we compare the extend, and rate, of destaining in control and AZ-
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treated muscles incubated in bicarbonate or in Hepes buffer solution and stimulated at 50 
Hz. Figure 2D shows that the slowing effect of AZ on FM destaining is completely 
suppressed by the presence of the strong buffer capacity of Hepes buffer. After prolonged 
stimulation, fluorescence loss in AZ treated muscles in Hepes buffer was 67±2% with and 
exponential decay tau of 53±13 (n=5) similar to non-treated control muscles (74±4%, tau: 
59±7, n=8, p=0.35). In contrast, fluorescence loss and tau were much reduced, (32±6%, 
tau: 24±2, n=7) in AZ treated compare to non treated control bicarbonate buffer (76±4%, 
tau: 52±13, n=7, p=0.007). In summary, in the experiments performed in Hepes buffer 
(control and AZ NMJs) vs bicarbonate AZ treated NMJs, the fluorescence loss was 
significantly different (p=0.0095 and 0,026 respectively). Data obtained from 3 muscles in 
Hepes and 4 muscles in bicarbonate buffer. 
  
Bromophenol (BPB) is able to quench dye retained in synaptic vesicle 
We have shown that in the presence of AZ, NMJs stimulated at 50 Hz continue to release 
ACh but much less FM dye was released than predicted by the summed quantal content 
(Fig 2E). The retained dye could result from the reuse of a fraction of vesicles already 
destained during previous fusion or from fast exo/endocytosis cycles preventing dye 
unloading, but allowing ACh release.  
 
To further test whether FM dye is retained in synaptic vesicles after exocytosis we used 
BPB a small negatively charged molecule capable of quenching the fluorescent dye inside 
the vesicles even during rapid endocytosis or/and in the absence of full vesicle fusion 
(Harata et al., 2006).Therefore, in the presence of BPB all the vesicles that undergo 
exocytosis will be quenched. This should give us some insight whether a fraction  of 
vesicles are rapidly reused or most of the vesicles undergo a fast endo/exocitotic 
recycling.  
After synaptic vesicles were fully loaded with FM dye and the dye was removed from the 
bath, BPB was applied to reach a 1 mM concentration. To overcome the light filtering 
effect produced by the presence of BPB solution between the nerve terminal and the 
objective we used a 40x short distance objective. Although the overall signal was reduced, 
it was enough to record the time course and extend of fluorescence loss during a 50 Hz 
stimulation train. As shown in Fig 3, AZ-treated and control muscles show no differences 
in fluorescence loss in the presence of 1mM BPB-bicarbonate buffer condition (AZ: 
62.1±8,8% loss, decay tau=41±13(n=5); control: 56.7±6,3% loss, decay tau=42±9 (n=3)). 
Thus the similar decrease in fluorescence in the presence or absence of AZ makes unlikely 
that AZ is promoting a rapid reuse of a fraction of vesicles suggesting that a fraction of 
vesicles undergo fast endocytosis.  
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AZ reduces SypHy signal upon HFS. 
To further explore the role of CA on transmitter release we studied the effect of AZ on 
presynaptic exocytosis and vesicle recycling in transgenic mice expressing SypHy. This 
fluorophore is tethered inside synaptic vesicles, where its fluorescence is acid-quenched. 
Upon exocytosis, SypHy is dequenched, and the fluorescence signal rises. Endocytosis and 
reacidification reverse the process (Tabares et al., 2007; Cano et al., 2012). During 
repetitive stimulation, the peak amplitude of the fluorescence change depends not only 
on the amount of pHluorin incorporated in the plasma membrane during exocytosis but 
also on that retrieved by endocytosis (Sankaranarayanan& Ryan, 2001).  
 
We first compared the fluorescence responses of nerve terminals in the absence and the 
presence of 100 μM AZ in preparations bathed with the standard extracellular solution 
containing bicarbonate and gassed with 5% CO2/95% O2. The basal fluorescence at the 
nerve terminal was not significantly different in the absence or the presence of the drug 
(1721 ± 309 vs 1401 ± 384 a.u, respectively; n = 6). We found that after 30 min incubation 
with AZ the peak amplitude of the fluorescent signal decreased in comparison with the 
response to the first train of stimulation in the absence of AZ (Fig. 4A, n = 6), but did not 
affect the recovery of fluorescence after the stimulus train (Fig. 4B). In the absence of AZ, 
the fluorescence peak amplitude during the second train was not significantly different to 
that of the first train (n= 3; p = 0.77); however, in the presence of the drug the peak 
decreased about 50% (n= 6; p = 0.0008) (Fig. 4C). The fluorescence decay time constants 
of the second train normalized to the first train did not significantly change neither in 
presence nor absence of the drug (Fig. 4D). The fluorescence change versus time of the 
first and second responses in control conditions (upper lower panel) and in the 
presence/absence of AZ (lower panel) are shown in Figure 4E. 
To investigate if the effect of AZ on the amplitude of the fluorescent response was pH-
dependent, we performed the same experiments in Hepes buffer extracellular solution. 
Figure 4F-H shows that neither the peak amplitude of the fluorescent responses during 
the trains or the decay kinetics after the stimuli were affected by the presence of AZ in the 
solution (n = 3). 
AZ enhances MLCK phosphorylation. 
In agreement with previous reports, our data suggest that HFS at the adult mouse NMJ 
switches the mechanism of vesicle cycling to a rapid-reuse mode (Maeno-Hikichi et al., 
2011). MLCK is known to regulate vesicle trafficking and synaptic transmission, and 
activation of MLCK accelerates both slow and rapid forms of vesicle endocytosis at the 
calyx nerve terminals (Yue and Xu, 2014). MLCK signaling pathway is required to maintain 
effective transmission at high stimulation frequencies (Polo-Parada et al., 2001, 2004). 
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Furthermore, it has also been reported that AZ induces phosphorylation of myosin kinase 
facilitating the translocation of membrane proteins onto cell membrane (Zhang et al., 
2012). To investigate the possible involvement of the MLCK in the mechanism of action of 
AZ we studied the state of phosphorylation of the enzyme in AZ treated stimulated (50 
Hz), and none stimulated muscles. 
To evaluate the state of phosphorylation of the MLCK, we performed 
immunohistochemistry using an antibody against phospho-myosin light chain 2. This 
antibody was previously used to demonstrate the involvement of MLCK activation at HFS 
(Maeno-Hikichi et al., 2011). Muscles were kept in control saline with or without AZ for at 
least 30 minutes before 50 Hz stimulation was applied for 10 min. Before the end of 
stimulation (30 s), muscles were fixed with paraformaldehyde and processed for 
immunohistochemistry evaluation (see Methods). Fig 5 shows confocal endplates images 
where the pMLC2 positive staining co-localized with the postsynaptic marker α-
bungarotoxin-FITC. The degree of pMLC2 labeling was much larger in stimulated endplates 
at 50 Hz, and the staining was significantly increased when AZ was applied. As a control, 
the fluorescent signals of pMLC2 in muscles treated with TPA (20 µM) were measured and 
found to be significantly increased.  
 
Discussion 
In this work we confirm that at the adult mice NMJ, AZ generates a small reduction on 
transmitter release quantal output at low stimulation frequency, in agreement with a 
previous report (Kaja et al., 2008). However, by combining electrophysiological data and 
optical evaluation of vesicle exocytosis at different frequencies we observed that AZ 
treatment results in dissociation between quantal output and vesicle destaining. 
 
One of the characteristics of exo/endocytosis during HFS is that allows the complete 
release of acetylcholine but partially impedes the exchange of molecules partitioned with 
the membrane like FM styryl dyes (Stevens and Willams, 2000; Pyle et al., 2000). We have 
shown that the amount of FM fluorescence loss differs at different stimulation 
frequencies even for the same number of vesicles undergoing exocytosis. At 10 and 50 Hz, 
stimulation fluorescence loss was rapid, however, at 100 Hz, much less dye was lost. This 
lower amount of destaining suggests that the actual release mechanism may have 
changed with high frequency stimulation. As postulated by Maeno-Hikichi et al. (2011) 
differences in destaining rate between different stimulation regimes is not due to a 
different degree of depression but to a distinct form of exo-endocytosis that loses less FM 
dye. On top of this frequency modulation, treatment with AZ strongly reduces 
fluorescence loss at 50 Hz stimulation with no effect on FM fluorescence loss at 10 Hz 
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indicating that AZ shifts the threshold to change the release mode to lower frequency 
values suggesting a synergic effect of HFS and CA inhibition. Furthermore, at motor nerve 
terminals of transgenic mice expressing SypHy the fluorescence responses to a 50 Hz train 
in the presence of AZ was decrease to a 50%. It is unlike that the decrease in peak 
amplitude of the fluorescent signal could be due to a reduction in exocytosis since AZ 
treatment results in a negligible reduction in quantal content. Alternative explanations are 
rapid endocytosis and reacidification resulting from  a more acid cytosolic environment, or 
an increase in rapid local vesicle recycling. An indication that AZ affects release mode 
resulting in retention of FM dye in synaptic vesicles after exocytosis is provided by BPB 
quenching effect. Due to its small size and charge BPB easily enters and quench any 
remaining intravesicular fluorescence suggesting that AZ together with HFS favor a “kiss-
and-run” mode of vesicle exocytosis instead a fast local reuse recycling mode which will 
quench only a limited number of vesicles. 
Inhibitors of the CA enzyme like AZ are used to treat ataxias, dizziness and other 
neurological syndromes (Bagnato and Good, 2016; Kotagal, 2012; Ogawa, 2004). CA is 
present in many tissues of the body, including the brain, where catalyzes a reversible 
reaction between CO2 hydration and HCO3
−
 dehydration. However, the mechanisms of 
how this therapeutic effect is achieved are not known (Ruusuvuori and Kaila, 2014; Bueno-
Junior et al., 2017).  
Zhang et al. (2010) used the pH-sensitive fluorescence of Yellow Fluorescent Protein 
transgenically expressed in mouse motor nerve terminals to report pH changes due to 
presynaptic stimulation. Ca
2+
 influx elicited by action potential trains evokes a biphasic 
intracellular pH change composed by a brief initial acidification followed by a prolonged 
alkalinization which outlasts the stimulation train. The initial acidification results from the 
extrusion of the elevated cytosolic [Ca
2+
] by activation of the plasma membrane Ca
2+
 -
ATPase (PMCA), which admits H
+
 to the nerve terminal and extrudes Ca
2+
 to the 
extracellular space. At this stage, H
+ 
entry via the PMCA exceeds H
+ 
extrusion via other 
transporters and particularly the vesicular H
+
-ATPase (vATPase). The incorporation of 
vATPase in the presynaptic membrane due to the collapse of synaptic vesicles results in a 
strong efflux of H
+
. This later alkalinization seems to facilitate clathrin-dependent 
endocytosis. On the other hand, the initial cytosolic acidification could reduce the 
sensitivity of internalization of clathrin-coated pits from the plasma membrane and of 
dynamin-adaptin binding (Sandvig et al., 1987; Davoust et al., 1987; Heuser, 1989a; Wang 
et al., 1995) reducing clathrin-dependent endocytosis. Interestingly, AZ as shown by Zhang 
et al. (2010) increases the initial acidification without much effect on the alkalinization. 
Therefore, it is possible that acidification will promote a clathrin-independent endocytosis 
mode, in agreement with the effect of AZ on FM destaining. Further indications that AZ 
mechanism of action involves intracellular pH changes derive from experiments where the 
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dissociation observed between transmitter release and FM destaining in AZ treated NMJs 
was abolished in the presence of a Hepes high buffer capacity bath solution. Similarly, high 
buffer capacity abolishes the reduction in the SypHy fluorescence responses to a 50 Hz 
train in the presence of AZ observed in bicarbonate/CO2 buffer. 
It has been demonstrated that MLCK is an important activity-dependent regulator of 
synaptic strength in several synapses. MLCK plays a crucial role in determining the size of 
the pool of synaptic vesicles that undergo fast release at a central nervous system 
synapses (Srinivasan et al., 2008; Gonzalez-Forero at al., 2012). At the NMJ, MLCK activity 
following repetitive stimulation is required to convey and/or exocytose synaptic vesicles at 
sufficient rates to maintain effective transmission (Polo-Parada et al., 2005; Maeno-Hikichi  
et al., 2011). In many cellular functions, MLCK acts downstream of Ca
2+
/calmodulin and 
activates the functions of myosin by phosphorylation of its regulatory light chain. Activity-
dependent regulation of endocytosis is a multiple steps process that involves many 
different lipid and protein molecules (Saheki and De Camilli 2012). Indeed, endocytosis is 
significantly accelerated in response to strong Ca
2+
 and, may be achieved through 
different pathways including a recently proposed calmodulin/MLCK/myosin pathway. Li et 
al. (2016), have recently shown that MLCK at hippocampal boutons functions downstream 
of Ca
2+
 /calmodulin to facilitate endocytosis through phosphorylation of MLC. At the NMJ 
Maeno et al., 2011 have shown that MLCK–myosin II pathway was required for effective 
transmission at 100Hz and that activation of MLCK, reduces the amount of FM dye lost 
suggesting that activation of the enzyme switches the mechanism of vesicle cycling to a 
rapid-reuse mode and is required to sustain effective transmission in adult mouse NMJ. In 
agreement with the reported role of MLCK, our immunohistochemistry experiments 
performed to evaluate the state of phosphorylation of the MLCK have shown that NMJ 
labeled with an antibody against phospho-myosin light chain was much larger in 
stimulated endplates at 50 Hz, and the staining was significantly increased when 
stimulation and AZ treatment were combined. Interestingly, there are some evidence that 
MLCK activity is altered by pH changes (Blumenthal and Stull, 1982) and also there are 
some indications of a possible direct activation of myosin kinases by AZ (Zhang et al., 
2012) in human kidney cells. Thus, Ca
2+
 levels, acidification and direct effect on the 
enzyme could mediate AZ activation of MLCK, but the precise mechanisms need to be 
further investigated. Other factors like temperature, known to affect the rate of 
endocytosis and vesicle mobilization (Kushmerick et al., 2006, Renden and von Gersdorff, 
2007, and Ruiz et al., 2011), that might also change the mode of vesicle recycling need 
further experimental validation. 
In summary, the present study suggests that AZ via cytosol acidification and activation of 
MLCK accelerates vesicle endocytosis in synapses what can contribute to sustain 
neurotransmission during repetitive activity. This effect of AZ could modify synaptic 
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performance in CNS synapses contributing to the therapeutic action reported in many 
neurological syndromes like ataxia, epilepsy and migraine. 
 
FIGURE LEGENDS 
Figure legends 
 
Figure 1: Effect of AZ on spontaneous and evoked neurotransmitter release  
Mean MEPP amplitudes in control and AZ treated muscles were similar (A) while 
augmented MEPP mean frequency was observed in AZ treated muscles (B). AZ reduces the 
mean quantal content at low stimulation frequency (0.33 Hz) (C). However, no differences 
were observed when transmitter release was evoked at high frequency (50 Hz). EPPs 
normalized amplitudes vs number of stimuli shows similar depression for control and AZ 
treated muscles when stimulated at 50 Hz (D). Summed EPP amplitudes during high 
frequency stimulation trains showed no significant differences between control (n =12/4) 
and AZ-treated (n = 19/5) terminals (E). (F) Representative EPP traces at 50 Hz frequency 
stimulation. Note the huge amplitude reduction after long lasting stimulation of control 
(black trace) and AZ-treated (gray trace) muscles. Scale bars: 1 mV, 10 ms (G) 
Representative traces of EPPs when bursts stimulation was performed. Absolute and 
relative depressions were not different. Scale bars: 10 mV, 10 ms 
Figure 2: FM destaining at 50Hz is strongly reduced by AZ in bicarbonate but not in 
Hepes buffer.  
(A) Examples of fluorescent endplates images, stained with FM 2-10 at the beginning, 
middle and end of the high frequency stimulation protocol (50Hz). (Scale bar, 10 µM). (B, 
C) Destaining under different frequency stimulation protocols in bicarbonate buffer, 
showing destaining kinetics and normalized fluorescence loss (FL) for control and AZ 
treated muscles. FL after 5000 stimuli (C) at low frequency stimulation protocol (10 Hz) 
was 46±3%, tau=66±13 s, n=5 for control and 44±2%, tau: 50±12 s, n=5 for AZ treated 
muscles. At 50 Hz stimulation protocol, FL was 49±9%, tau: 76±4 s, n=7 and 19±4%, tau: 
24±2 s., n=7 for control and AZ treated muscles respectively. At 100 Hz stimulation 
protocol, FL was 34±2% n=6, tau: 26±2 s for control and 27±3%, tau: 24±2 s n=6, for AZ 
treated muscles. Data from 3 to 4 muscles. (D) 50Hz stimulation protocol was performed 
in bicarbonate and in stronger buffer capacity (Hepes 10mM) for 20000 stimuli to study 
long lasting unloading dynamics in control and AZ treated muscles. In Hepes buffer, 
destaining in AZ treated muscles was 67±2%, tau: 53±13sec, n=5, and for control was 
74±4%, tau: 59±7sec n=8, (p=0.3481), while in bicarbonate buffer AZ treated muscles 
destaining was 32±6%, tau:24±2sec n=7 and for control 76±4%, tau:52±13sec n=7 
(p=0.0071). Data obtained from 3 to 4 muscles. (E) Normalized loss of fluorescence 
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intensity vs summed normalized amplitude at 50Hz stimulation protocol shows the linear 
correlation between the imaging and electrophysiological experiments for control muscles 
f=y0+a*x where y0=1.4 and a=0.02 while for AZ treated muscles the adjustment was 
exponential rise to maximum, single, two parameters.  f=a*(1-exp(-b*x)) where a=26 and 
b=6x10-4. 
Figure 3: Retained FM dye-quenched by Bromophenol reveal that most dye-loaded 
vesicles are exocytosed at 50 Hz in the presence of AZ. 
(A) Bromophenol Blue (2mM) was applied at control and AZ treated muscles in 
bicarbonate buffer and a 50Hz unloading protocol was applied. (B) AZ treated muscles 
showed a fraction of fluorescence loss of similar to the fraction of fluorescence loss at 
control muscles (62.1 ± 8,8%, tau = 41 ± 13s. ,n = 5 vs 56-7± 6,3%, tau = 42 ± 9s ,n = 3. t-
test p>0.05)-Data obtained from 3 muscles  in control and 5 muscles in AZ 
Figure 4: AZ decreases the amplitude of the fluorescent response in SypHy motor nerve 
terminals. 
(A) Change in peak fluorescence amplitude in response to two stimulation trains (50 Hz, 
75 s) in the absence (1
st
train, t = 0) and in the presence of 100 µM AZ (2
nd
train, t = 30 min). 
Note that AZ reduced the amplitude of the responses in all cases (n= 6, 6 muscles). 
(B)Fluorescence decay time constants after stimulation in the absence and in the presence 
of the drug, same terminals as in A. (C) In the absence of the drug, the mean peak 
response to the second train, normalized to the first train amplitude, did not change 
(white bar); (n = 3). In the presence of AZ (dark bar), the mean response was significantly 
reduced during the second train (n= 6). (D) The normalized mean time constants of the 
fluorescence decay were not different in the absence (white bar) or in the presence of the 
drug AZ (dark bar). (E)Upper graph: first (black trace) and second (light trace) responses to 
the two stimulation trains in the absence of the drug. Lower graph: mean time course of 
the fluorescence change in response to the first train in the absence (black) and after 30 
min incubation with AZ (grey). F-H: same as before but using Hepes instead 
of bicarbonate/CO2buffer (n = 3).Error bars are s.e.m. ***p =0.0008. 
Figure 5: pMLC2 is upregulated with 50 Hz stimulus and AZ treatment.(A) Examples of 
confocal endplates images, staining in green with alpha-bungarotoxin- FITC, showing 
pMLC2 positive staining (red). Note that pMLC2 labeling was much larger in stimulated 
endplates at 50 Hz, and the staining was significantly increased when AZ (100 μM) was 
applied. pMLC2 staining was significantly increased with TPA (20 μM). (B) Histogram 
showing pMLC2 positive endplates as normalized mean fluorescence intensity from 
control; n = 41-22 from 3 different muscles. 
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Graphical Abstract 
Acetazolamide (AZ) an inhibitor of an enzyme that regulates pH inside and outside the 
cells is used to treat ataxia and epilepsy. Combined experiments using fluorescence dyes 
and electrophysiological techniques at the mice neuromuscular junction suggests that AZ 
shift synaptic vesicle recycling to a fast mode which may contribute to the therapeutic 
action reported. 
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Figure 1: Effect of AZ on spontaneous and evoked neurotransmitter release  
Mean MEPP amplitudes in control and AZ treated muscles were similar (A) while augmented MEPP mean 
frequency was observed in AZ treated muscles (B). AZ reduces the mean quantal content at low stimulation 
frequency (0.33 Hz) (C). However, no differences were observed when transmitter release was evoked at 
high frequency (50 Hz). EPPs normalized amplitudes vs number of stimuli shows similar depression for 
control and AZ treated muscles when stimulated at 50 Hz (D). Summed EPP amplitudes during high 
frequency stimulation trains showed no significant differences between control (n =12/4) and AZ-treated (n 
= 19/5) terminals (E). (F) Representative EPP traces at 50 Hz frequency stimulation. Note the huge 
amplitude reduction after long lasting stimulation of control (black trace) and AZ-treated (gray trace) 
muscles. Scale bars: 1 mV, 10 ms (G) Representative traces of EPPs when bursts stimulation was 
performed. Absolute and relative depressions were not different. Scale bars: 10 mV, 10 ms 
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Figure 2: FM destaining at 50Hz is strongly reduced by AZ in bicarbonate but not in Hepes buffer.  
(A) Examples of fluorescent endplates images, stained with FM 2-10 at the beginning, middle and end of the 
high frequency stimulation protocol (50Hz). (Scale bar, 10 µM). (B, C) Destaining under different frequency 
stimulation protocols in bicarbonate buffer, showing destaining kinetics and normalized fluorescence loss 
(FL) for control and AZ treated muscles. FL after 5000 stimuli (C) at low frequency stimulation protocol (10 
Hz) was 46±3%, tau=66±13 s, n=5 for control and 44±2%, tau: 50±12 s, n=5 for AZ treated muscles. At 
50 Hz stimulation protocol, FL was 49±9%, tau: 76±4 s, n=7 and 19±4%, tau: 24±2 s, n=7 for control and 
AZ treated muscles respectively. At 100 Hz stimulation protocol, FL was 34±2% n=6, tau: 26±2 s for 
control and 27±3%, tau: 24±2 s n=6, for AZ treated muscles. Data from 3 to 4 muscles. (D) 50 Hz 
stimulation protocol was performed in bicarbonate and in stronger buffer capacity (Hepes 10 mM) for 20000 
stimuli to study long lasting unloading dynamics in control and AZ treated muscles. In Hepes buffer, 
destaining in AZ treated muscles was 67±2%, tau: 53±13 s, n=5, and for control was 74±4%, tau: 59±7 s 
n=8, (p=0.3481), while in bicarbonate buffer AZ treated muscles destaining was 32±6%, tau: 24±2 s n=7 
and for control 76±4%, tau: 52±13 s n=7 (p=0.0071). Data obtained from 3 to 4 muscles. (E) Normalized 
loss of fluorescence intensity vs summed normalized amplitude at 50 Hz stimulation protocol shows the 
linear correlation between the imaging and electrophysiological experiments for control muscles f=y0+a*x 
where y0=1.4 and a=0.02 while for AZ treated muscles the adjustment was exponential rise to maximum, 
single, two parameters.  f=a*(1-exp(-b*x)) where a=26 and b=6x10-4.  
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Figure 3: Retained FM dye-quenched by Bromophenol reveal that most dye-loaded vesicles are exocytosed 
at 50 Hz in the presence of AZ. 
(A) Bromophenol Blue (2 mM) was applied at control and AZ treated muscles in bicarbonate buffer and a 50 
Hz unloading protocol was applied. (B) AZ treated muscles showed a fraction of fluorescence loss of similar 
to the fraction of fluorescence loss at control muscles (62.1 ± 8,8%, tau = 41 ± 13 s ,n = 5 vs 56.7± 6,3%, 
tau = 42 ± 9 s ,n = 3. t-test p>0.05)-Data obtained from 3 muscles  in control and 5 muscles in AZ 
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Figure 4: AZ decreases the amplitude of the fluorescent response in SypHy motor nerve terminals. 
(A) Change in peak fluorescence amplitude in response to two stimulation trains (50 Hz, 75 s) in the 
absence (1sttrain, t = 0) and in the presence of 100 µM AZ (2nd train, t = 30 min). Note that AZ reduced 
the amplitude of the responses in all cases (n= 6, 6 muscles). (B)Fluorescence decay time constants after 
stimulation in the absence and in the presence of the drug, same terminals as in A. (C) In the absence of 
the drug, the mean peak response to the second train, normalized to the first train amplitude, did not 
change (white bar); (n = 3). In the presence of AZ (dark bar), the mean response was significantly reduced 
during the second train (n= 6). (D) The normalized mean time constants of the fluorescence decay were not 
different in the absence (white bar) or in the presence of the drug AZ (dark bar). (E)Upper graph: first 
(black trace) and second (light trace) responses to the two stimulation trains in the absence of the drug. 
Lower graph: mean time course of the fluorescence change in response to the first train in the absence 
(black) and after 30 min incubation with AZ (grey). F-H: same as before but using Hepes instead of 
bicarbonate/CO2 buffer (n = 3).Error bars are s.e.m. ***p =0.0008. 
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Figure 5: pMLC2 is upregulated with 50 Hz stimulus and AZ treatment.(A) Examples of confocal endplates 
images, staining in green with alpha-bungarotoxin- FITC, showing pMLC2 positive staining (red). Note that 
pMLC2 labeling was much larger in stimulated endplates at 50 Hz, and the staining was significantly 
increased when AZ (100 µM) was applied. pMLC2 staining was significantly increased with TPA (20 µM). (B) 
Histogram showing pMLC2 positive endplates as normalized mean fluorescence intensity from control; n = 
41-22 from 3 different muscles.  
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